Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Respect to anyone who locks in a profit. So many small investors fail to do it time after time.
Can't blame you, could get messy here. Board will think its worth more than the offer no doubt, but perhaps there is enough of a disgruntled base that they can get a hostile bid over the line. A low ball offer could also expose the company to a bidding war. There are at least 2 parties now which think that the company is undervalued. How many more are there? At its peak it hit 1200p and big things are being predicted for the pharm sector. Although they don't have a huge stake having Eliot on board should make for some drama at least
I'm out too, happy with my profit
I don't know either how Elliot will play it, but I won't be around to find out having taken that 20% return this lunchtime. Ammo is required in this falling market! Best of luck investors.
We need 900p above offer, Clinigen is too valuable below that price!!
Wonder how Elliott will play it? They were buying in the low 600p through summer and saw value presumably in a break up of products and services. I'd speculate they'd want a better return than ~20%. As would I.
These guys will be out to get it as cheap as possible, you know it’s how they play the game. Probably why the share price has been suppressed of late ..7.50 to 7.80 would be my max guess…let’s see..
Be interesting to see if the price settles above that though?
Liberum analysts price target was 8.00 lowered from 8.86p
The SP was £8.50 in June and pre covid £9.50, I would be surprised and pretty disappointed if it went for less than £8. A 30% premium on a heavily depressed base of 6 would at least get to 7.80. Something too low would be seen as extremely opportunistic
7.50 GBP per share is my guess.
https://www.investegate.co.uk/clinigen-group-plc--clin-/rns/statement-re-possible-offer/202112021245024003U/
Shorts will be squeeming